Skip to search formSkip to main contentSkip to account menu

palonosetron

Known as: (3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one, Palonosetronum, palonosetron [Chemical/Ingredient] 
The active ingredient in a drug used to treat nausea and vomiting caused by cancer treatment. Palonosetron is a type of serotonin receptor antagonist… 
National Institutes of Health

Related topics

Related topics

10 relations
5 ML palonosetron 0.05 MG/ML Injection [Aloxi]Serotonin 3 Receptor Antagonists [MoA]netupitant / palonosetronnetupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]

Narrower (3)

AloxiPalonosetron hydrochlorideRS 25259

Broader (3)

IsoquinolinesQuinuclidinesSerotonin Antagonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Comparison between palonosetron and ramosetron to prevent postoperative nausea and vomiting in patients undergoing laparoscopic surgery
Introduction and Aims: Postoperative nausea and vomiting (PONV) are very common and distressing adverse events after general… 
2016
2016
Development of Transdermal Delivery System of Dexamethasone, Palonosetron and Aprepitant for Combination Antiemetic Therapy
Purpose: The objective of this study was to assess the possible transdermal delivery for combination antiemetic therapy of… 
2015
2015
Comparison of Ramosetron and Palonosetron for Control of Post-operative Nausea and Vomiting following Middle Ear Surgeries: A Prospective Randomized Double-blind Study
Background: Post-operative nausea vomiting (PONV) is a distressing complaint particularly in high-risk patients. 5-HT3 receptor… 
2014
2014
A comparative study of prophylactic ondansetron versus palonosetron for post operative nausea and vomiting in middle ear surgeries
Objectives-Postoperative nausea and vomiting (PONV) is a common complication in patients undergone middle ear surgeries under… 
2013
2013
COMPARISON BETWEEN EFFICACY OF PALONOSETRON AND ONDANSETRON IN POSTOPERATIVE NAUSEA AND VOMITING IN MIDDLE EAR SURGERY: A RANDOMIZED DOUBLE BLIND STUDY.
OBJECTIVE: Postoperative nausea and vomiting (PONV) is a common complication in patients after middle ear surgeries conducted… 
2012
2012
A comparative study between palonosetron and ramosetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy
Post operative nausea and vomiting (PONV) is common after laparoscopic surgery. Vomiting may create problems like electrolyte… 
2012
2012
갑상선절제술 후 48시간 동안 수술 후 오심과 구토에 대한 palonosetron과 ondansetron의 효과 비교
Review
2010
Review
2010
Reducing Human Error in Checking Concomitant Medications
Subject safety and scientific validity require sites to avoid enrolling subjects who are taking certain “concomitant” medications… 
2008
2008
Palonosetron (PALO) for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose melphalan prior to stem cell transplant (SCT)
9617 Background: PALO, a novel 5HT3 receptor antagonist with unique pharmacologic features, is approved as a 0.25-mg IV dose and… 
2003
2003
Palonosetron: A novel 5-HT3 receptor antagonist for chemotherapy-associated nausea and vomiting
Nausea and vomiting are among the serious complications of chemotherapy and can be associated with medical and psychological…